Cold, cough, and sore throat are common infections occurring due to different viruses and can be easily treated with various medications such as antihistamines, expectorants, bronchodilators, decongestants, and others. Increasing prevalence of viral infections causing cold and flu is creating a favorable environment for growth of global cold, cough, and sore throat remedies market. According to Australian Health Direct, over 200 viruses present worldwide can cause cold and adults are susceptible to these viruses around 2-4 times annually. The same source also suggests that the cold and flu symptoms are usually mild to moderate and self-limiting, which is propelling demand for over-the-counter drugs, in turn fueling growth of the market.

Restraints of the Global Cold, Cough, and Sore Throat Remedies Market

Alternative treatment options such as home remedies, and others are used in emerging economies which restrains growth of the market up to certain extent.

Key features of the study

• This report provides in-depth analysis of the global cold, cough, and sore throat remedies market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global cold, cough, and sore throat remedies market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Reckitt Benckiser Group PLC, Johnson & Johnson Services, Inc., GlaxoSmithKline plc., Novartis AG, Bayer AG, AstraZeneca plc., Sun Pharmaceutical Industries Ltd., Pfizer Inc., Prestige Brands Holdings, Inc., and Procter & Gamble Co.
• Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• The global cold, cough, and sore throat remedies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

 Market Segmentation

• By Drug Type
  • Antihistamines
  • Expectorants
  • Bronchodilators
  • Decongestants
  • Antibiotics
  • Others
• By Formulation
  • Oral Syrups
  • Tablets/Pills
  • Nasal Drops
  • Lozenges
  • Others
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Supermarkets/Hypermarkets
  • e-Commerce/Online Pharmacies
• By Region
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa
• Competitive Landscape
  • Reckitt Benckiser Group PLC
  • Johnson & Johnson Services, Inc.
  • GlaxoSmithKline plc.
  • Novartis AG
  • Bayer AG
  • AstraZeneca plc.
  • Sun Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Prestige Brands Holdings, Inc.
  • Procter & Gamble Co.